$59.44
-1.18-1.95%
가까이에: Sep 25, 5:00 PM EST
$59.00
-0.44-0.74%
시간외: 6:03 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 26
Travere Therapeutics Inc
TVTXNASDAQ
Travere Therapeutics Earnings & Forecasts
Travere Therapeutics (TVTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Travere Therapeutics Guidance
Travere Therapeutics (TVTX)는 1월 9, 2023에 fiscal year 2022에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $212M - $212M 범위로 예상했습니다.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.23 | $-0.10 | $0.24 | $-0.17 |
| Actual | $-0.10 | $0.05 | $0.37 | $0.59 |
| Surprise | -143.5% | +150.0% | +54.2% | +447.1% |
| Revenue | ||||
| Estimate | $159.3M | $135.3M | $145.6M | $105.0M |
| Actual | $169.6M | $127.2M | $129.7M | $164.9M |
| Surprise | +6.44% | -6.01% | -10.9% | +57.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.43 | $0.98 | $0.56 | $0.80 |
| Revenue | ||||
| Consensus | $194.9M | $231.5M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved